FAERS manufacturer drug profile

SERTRALINE · NOVARTIS

FAERS manufacturer and drug safety profile

Key facts

Drug SERTRALINE
Manufacturer (report sender) NOVARTIS

At a glance

  • 1,000+ FAERS reports from this manufacturer
  • 100–999 Reports with death as outcome
  • 1,000+ Reports with hospitalization
  • 100–999 Life-threatening outcomes
  • 1,000+ Distinct reaction terms reported
  • 1,000+ Reactions flagged by Orca1 signal analytics
  • Yes Serious outcome flagged by Orca1 signal analytics
  • Other Serious, Hospitalization, Death, Life-Threatening, Disability, Congenital Anomaly Outcome categories reported

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FAERS manufacturer and drug safety profiles

Manufacturer drug profiles aggregate the FAERS reports that one manufacturer sent to the FDA naming the drug as a suspect product, so the same drug can be compared across manufacturers. Reaction terms are counted but not listed here; reports are unverified and do not by themselves establish causation.

Source: U.S. Food and Drug Administration (FDA), FAERS public data; aggregation by Orca1

Browse all FAERS manufacturer and drug safety profiles